The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Nanoparticle-based drug delivery systems for cancer therapy
Open accessAbstract
Nanoparticle-based drug delivery system (DDS) is considered promising for cancer treatment. Compared with traditional DDS, the nanoparticle-based DDS shows improved efficacy by: 1) increasing half-life of vulnerable drugs and proteins, 2) improving the solubility of hydrophobic drugs, and 3) allowing controlled and targeted release of drugs in diseased site. This review mainly focuses on nanoparticle-based DDS fabricated from chitosan, silica, and poly (lactic-co-glycolic acid). Their fabrication methods and applications in cancer treatment are introduced. The current limitations and future perspectives of the nanoparticle-based DDS are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., & Beck, J. S. (1992) · Nature · doi:10.1038/359710a0 · Cited by 16,275
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · cited 1×
“Researchers have reported that nanoparticles with a diameter of 50–100 nm have a higher accumulation in liver, spleen, and lung [64,65], leading to nonspecific accumulation of nanoparticles.”
BackgroundLiposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · cited 1×
“Controlled DDSs would be excellent carriers for chemotherapeutic agents, guiding the chemotherapeutic agents to the tumor site thus increasing the drug concentration in cancer cells and averting toxicity in normal cells [3,4].”
BackgroundDrug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Tang, F., Li, L., & Chen, D. (2012) · Advanced Materials · doi:10.1002/adma.201104763 · Cited by 2,836
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers
Calvo, P., Remu��n-L�pez, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Journal of Applied Polymer Science · doi:10.1002/(sici)1097-4628(19970103)63:1<125::aid-app13>3.0.co;2-4 · Cited by 1,856
Nanoparticle biointerfacing by platelet membrane cloaking
Hu, C.-M. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,789
Mesoporous silica nanoparticles for drug delivery and biosensing applications
Slowing, I. I., Trewyn, B. G., Giri, S., & Lin, V. S. ‐. (2007) · Advanced Functional Materials · doi:10.1002/adfm.200601191 · Cited by 1,699
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Mesoporous silica nanoparticles deliver DNA and chemicals into plants
Torney, F., Trewyn, B. G., Lin, V. S.-Y., & Wang, K. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.108 · Cited by 1,481
Continuous formation of supported cubic and hexagonal mesoporous films by sol–gel dip-coating
Lu, Y., Ganguli, R., Drewien, C. A., Anderson, M. T., Brinker, C. J., Gong, W., Guo, Y., Soyez, H., Dunn, B., Huang, M. H., et al. (1997) · Nature · doi:10.1038/38699 · Cited by 1,467
Nanoparticles as drug delivery systems
Wilczewska, A. Z., Niemirowicz, K., Markiewicz, K. H., & Car, H. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70901-5 · Cited by 1,445
Functionalized mesoporous silica materials for controlled drug delivery
Yang, P., Gai, S., & Lin, J. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15308d · Cited by 1,399
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Pinto Reis, C., Neufeld, R. J., Ribeiro, & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.12.003 · Cited by 1,354
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
Kim, J., Kim, H. S., Lee, N., Kim, T., Kim, H., Yu, T., Song, I. C., Moon, W. K., & Hyeon, T. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200802469 · Cited by 1,220
Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica
Mal, N. K., Fujiwara, M., & Tanaka, Y. (2003) · Nature · doi:10.1038/nature01362 · Cited by 1,094
Aerosol-assisted self-assembly of mesostructured spherical nanoparticles
Lu, Y., Fan, H., Stump, A., Ward, T. L., Rieker, T., & Brinker, C. J. (1999) · Nature · doi:10.1038/18410 · Cited by 985
Mesoporous Silica Nanoparticle Nanocarriers: Biofunctionality and Biocompatibility
Tarn, D., Ashley, C. E., Xue, M., Carnes, E. C., Zink, J. I., & Brinker, C. J. (2013) · Accounts of Chemical Research · doi:10.1021/ar3000986 · Cited by 949
Xia, T., Kovochich, M., Liong, M., Meng, H., Kabehie, S., George, S., Zink, J. I., & Nel, A. E. (2009) · ACS Nano · doi:10.1021/nn900918w · Cited by 933 · cited 1×
“However, one of the drawbacks of PEI coated MSNs is that toxic PEI coating can increase the cytotoxicity of the MSNs delivery system [35].”
BackgroundYuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908
Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
Ventola, C. L. (2017) · Europe PMC (PubMed Central) · Cited by 835
Targeted delivery of low molecular drugs using chitosan and its derivatives
Park, J. H., Saravanakumar, G., Kim, K., & Kwon, I. C. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.003 · Cited by 821
Chitosan nanoparticles as delivery systems for doxorubicin
Janes, K. A., Fresneau, M. P., Marazuela, A., Fabra, A., & Alonso, M. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00294-2 · Cited by 721
Pan, Y., Li, Y.-J., Zhao, H.-Y., Zheng, J.-M., Xu, H., Wei, G., Hao, J.-S., & Cui, F.-D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00486-6 · Cited by 686
Chitosan Nanoparticles: A Promising System in Novel Drug Delivery
Nagpal, K., Singh, S. K., & Mishra, D. N. (2010) · CHEMICAL & PHARMACEUTICAL BULLETIN · doi:10.1248/cpb.58.1423 · Cited by 660
Sota, J., Insalaco, A., Cimaz, R., Alessio, M., Cattalini, M., Gallizzi, R., Maggio, M. C., Lopalco, G., La Torre, F., Fabiani, C., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01526 · Cited by 616
PLGA-Based Nanoparticles in Cancer Treatment
Rezvantalab, S., Drude, N. I., Moraveji, M. K., Güvener, N., Koons, E. K., Shi, Y., Lammers, T., & Kiessling, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01260 · Cited by 607
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Control of encapsulation efficiency and initial burst in polymeric microparticle systems
Yeo, Y., & Park, K. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980037 · Cited by 567
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Tabatabaei Mirakabad, F. S., Nejati-Koshki, K., Akbarzadeh, A., Yamchi, M. R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.517 · Cited by 542
Erbacher, P., Zou, S., Bettinger, T., Steffan, A.-M., & Remy, J.-S. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981000671 · Cited by 536
Multifunctional Nanoparticles for Drug Delivery and Molecular Imaging
Bao, G., Mitragotri, S., & Tong, S. (2013) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071812-152409 · Cited by 536
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
Meng, H., Xue, M., Xia, T., Ji, Z., Tarn, D. Y., Zink, J. I., & Nel, A. E. (2011) · ACS Nano · doi:10.1021/nn200809t · Cited by 509
Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles
Gao, W., Fang, R. H., Thamphiwatana, S., Luk, B. T., Li, J., Angsantikul, P., Zhang, Q., Hu, C.-M. J., & Zhang, L. (2015) · Nano Letters · doi:10.1021/nl504798g · Cited by 509
Park, C., Oh, K., Lee, S. C., & Kim, C. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200603404 · Cited by 453
Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A
El-Shabouri, M. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00461-1 · Cited by 392
Kim, M.-H., Na, H.-K., Kim, Y.-K., Ryoo, S.-R., Cho, H. S., Lee, K. E., Jeon, H., Ryoo, R., & Min, D.-H. (2011) · ACS Nano · doi:10.1021/nn103130q · Cited by 364
Controlled drug delivery with nanoparticles : current possibilities and future trends
Couvreur, P., Dubernet, C., & Puisieux, F. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 356
CHITOSAN NANOPARTICLES: A PROMISING SYSTEM FOR DRUG DELIVERY
Tiyaboonchai, W. (2003) · Asian Health, Science and Technology Reports · Cited by 341
Physico-Chemical Properties of Silica in Relation to its Toxicity
NASH, T., ALLISON, A. C., & HARINGTON, J. S. (1966) · Nature · doi:10.1038/210259a0 · Cited by 325
Schlossbauer, A., Kecht, J., & Bein, T. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805818 · Cited by 299
Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases
Gregoriadis, G., & Ryman, B. E. (1971) · Biochemical Journal · doi:10.1042/bj1240058p · Cited by 286
A Novel Approach to the Oral Delivery of Micro- or Nanoparticles
Bodmeier, R., Chen, H., & Paeratakul, O. (1989) · Pharmaceutical Research · doi:10.1023/a:1015987516796 · Cited by 276
Vårum, K. (2001) · Carbohydrate Polymers · doi:10.1016/s0144-8617(00)00288-5 · Cited by 269
Magnetic targeting for site-specific drug delivery: applications and clinical potential
Polyak, B., & Friedman, G. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802662795 · Cited by 260
Wang, Y., Li, P., Truong-Dinh Tran, T., Zhang, J., & Kong, L. (2016) · Nanomaterials · doi:10.3390/nano6020026 · Cited by 255
Cui, Y., Zhang, M., Zeng, F., Jin, H., Xu, Q., & Huang, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b10175 · Cited by 242
Zhang, H., Mardyani, S., Chan, W. C. W., & Kumacheva, E. (2006) · Biomacromolecules · doi:10.1021/bm050912z · Cited by 241
Wei, X., Gao, J., Fang, R. H., Luk, B. T., Kroll, A. V., Dehaini, D., Zhou, J., Kim, H. W., Gao, W., Lu, W., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.003 · Cited by 218
Nanoparticulate systems for the delivery of antisense oligonucleotides
Lambert, G., Fattal, E., & Couvreur, P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00116-2 · Cited by 201
Lai, P., Daear, W., Löbenberg, R., & Prenner, E. J. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.03.017 · Cited by 198
Mineral-Induced Formation of Reactive Oxygen Species
Schoonen, M. A. A., Cohn, C. A., Roemer, E., Laffers, R., Simon, S. R., & O'Riordan, T. (2006) · Reviews in Mineralogy and Geochemistry · doi:10.2138/rmg.2006.64.7 · Cited by 193
In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors
Jain, A., & Jain, S. K. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.08.008 · Cited by 169
Zhang, J.-Y., Shen, Z.-G., Zhong, J., Hu, T.-T., Chen, J.-F., Ma, Z.-Q., & Yun, J. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.05.048 · Cited by 165
Magnetic-Sensitive Silica Nanospheres for Controlled Drug Release
Hu, S.-H., Liu, T.-Y., Huang, H.-Y., Liu, D.-M., & Chen, S.-Y. (2008) · Langmuir · doi:10.1021/la701570z · Cited by 159
Hu, Y., Wang, J., Zhi, Z., et al. (2011) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.07.022 · Cited by 146
3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol
Hu, Y., Zhi, Z., Zhao, Q., et al. (2011) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2011.06.001 · Cited by 141
Biomimetic particles as therapeutics
Meyer, R. A., Sunshine, J. C., & Green, J. J. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.07.001 · Cited by 136
Niwa, T., Takeuchi, H., Hino, T., Kunou, N., & Kawashimà, Y. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830527 · Cited by 122
Braet, F., Wisse, E., Bomans, P. H. H., Frederik, P. M., Geerts, W. J. C., Koster, A. J., Soon, L., & Ringer, S. P. (2007) · Microscopy Research and Technique · doi:10.1002/jemt.20408 · Cited by 113
Sun, L., Wang, Y., Jiang, T., Zheng, X. S., Zhang, J., Sun, J., Sun, C., & Wang, S. (2012) · ACS Applied Materials & Interfaces · doi:10.1021/am302246s · Cited by 109
Isomaa, B., Reuter, J., & Djupsund, B. M. (1976) · Archives of Toxicology · doi:10.1007/bf00372762 · Cited by 93
Wang, Y., & Yuan, F. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9007-2 · Cited by 77
Nadrah, P., Porta, F., Planinšek, O., Kros, A., & Gaberšček, M. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp44614j · Cited by 65
Molecular stability of chitosan in acid solutions stored at various conditions
Nguyễn, T. T. B., Hein, S., Ng, C., et al. (2007) · Journal of Applied Polymer Science · doi:10.1002/app.27376 · Cited by 58
Tailoring magnetic PLGA nanoparticles suitable for doxorubicin delivery
Tansık, G., Yakar, A., & Gündüz, U. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-2171-7 · Cited by 42
Therapeutic Angiogenesis of PLGA‐Heparin Nanoparticle in Mouse Ischemic Limb
Lian, L., Tang, F., Yang, J., Liu, C., & Li, Y. (2012) · Journal of Nanomaterials · doi:10.1155/2012/193704 · Cited by 20
Cited by
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
Su, Y., Zhang, B., Sun, R., Liu, W., Zhu, Q., Zhang, X., Wang, R., & Chen, C. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1938756 · Cited by 617
Emerging Applications of Nanotechnology in Healthcare and Medicine
Malik, S., Muhammad, K., & Waheed, Y. (2023) · Molecules · doi:10.3390/molecules28186624 · Cited by 610
Advances in Chitosan-Based Nanoparticles for Drug Delivery
Mikušová, V., & Mikuš, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179652 · Cited by 581
Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601626 · Cited by 571
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
Metadata
- Authors
- Dang, Y., & Guan, J.
- Venue
- Smart Materials in Medicine
- Publisher
- Elsevier BV
- Published
- 2020
- Volume
- 1
- Pages
- 10-19
- ISSN
- 2590-1834 (ISSN-L)
- OpenAlex
- W3017040627
- Cited by
- 553
- References
- 79
- FWCI
- 16.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.